Heavy Bleeding: DOACs in Obesity
This activity is available to Houston Methodist employees and students only.
This continuing education program will discuss changes in patients with obesity and offer insight on dosing of DOACs in that population.
This activity is open to all Houston Methodist health care professionals.
1. Evaluate the pharmacokinetic changes seen in patients with obesity
2. Develop an evidence-based anticoagulation regimen for patients with obesity with atrial fibrillation, VTE, or prevention of VTE
3. Assess the role of measuring peak and trough concentrations of drug specific DOAC levels
The Zoom link will be provided in the course instructions when you log in to the program.
Cyclene Ann G. Talabucon, PharmD
PGY1 Pharmacy Resident
Nitha Chou, PharmD, BCPS
Kathryn Pidcock, PharmD, BCPS
The speaker and content preceptors do not have anything to disclose in relation to the subject matter of this presentation.
Houston Methodist Hospital is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Participants documenting completion of the activity by attending the lecture, participating in the learning assessment, and completing an evaluation form within 30 days will receive 1.0 contact hour (0.1 CEU) of continuing pharmacy education credit as an application-based activity for pharmacists.
- 1.00 ACPE Pharmacist
Houston Methodist Hospital is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Participants documenting completion of the activity will receive up to 1.00 contact hours of continuing pharmacy education credit as Application activities for pharmacists.
- 1.00 Attendance